...
首页> 外文期刊>International Journal of Research in Medical Sciences >Comparative evaluation of phasic and chemical antinociceptive action of a conventional and a novel anticonvulsants in experimental models of tail flick and formalin test
【24h】

Comparative evaluation of phasic and chemical antinociceptive action of a conventional and a novel anticonvulsants in experimental models of tail flick and formalin test

机译:常规和新型抗惊厥药中常相和化学抗伤害作用的比较评价及术语 - 福尔马林试验模型

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: Some antiepileptic drugs have been shown to be clinically efficacious in treatment of neuropathic pain and are being used by clinician. Methods: This study determined the analgesic effect of gabapentin (a conventional anticonvulsant) and levitiracetam (a novel anticonvulsant) in rats in different types of acute and chronic nociceptive test like tail flick and formalin test and compared its potency with a conventional non opioid analgesic diclofenac. Results: Per oral administration of gabapentin produced no any marked effect on early phase response of formalin test but significantly suppressed the late phase response while levitiracetam produced no any type of significant effect in both phases. In tail flick test gabapentin as well as levitiracetam produced no any significant analgesic effect while diclofenac produced significant reduction of pain in tail flick test as well as in both phases of formalin test. Conclusions: Thus, we have observed that gabapentin produced antinociception in chronic pain as second phase of formalin test reflects chronic inflammatory pain while levitiracetam did not produce any type of antinociceptive effect as it could not suppress the pain significantly in both tail flick and formalin test.
机译:背景:一些抗癫痫药物已被证明是治疗神经病疼痛的临床效果,并被临床医生使用。方法:本研究确定了尾巴轻便和福尔马林试验等不同类型的急性和慢性伤害性试验中的加巴亨坦素(常规抗惊厥药)和左旋式抑制(一种新的抗惊厥药)(一种新的抗惊厥药)的镇痛作用,并将其与常规非阿片类药物镇痛的双氯芬酸相比其效力。结果:每次口服施用加巴彭素对福尔马林试验的早期阶段响应没有任何明显的影响,但随着两相的任何类型的效果没有任何类型的显着效果,显着抑制了晚期阶段响应。在尾部轻弹测试加布普坦蛋白以及Levitiracetam没有产生任何显着的镇痛作用,而Diclofenac在尾霉测试中产生显着降低尾部轻型测试以及福尔马林试验的两相。结论因此,我们已经观察到,随着福尔马林试验的第二阶段,加巴邦素在慢性疼痛中产生的慢性疼痛反映了慢性炎症疼痛,而Levitiracetam没有产生任何类型的抗血汗效果,因为它在尾部轻弹和福尔马林试验中不能显着抑制疼痛。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号